BioCentury | Jun 11, 2019
Company News

June 11 Company Quick Takes: Genmab, Janssen together again on CD38; plus GT Apeiron’s launch; BiomX, Aimmune, Keytruda

...AI play GT Apeiron launches with $27M, Exscientia deal GT Healthcare Capital Partners launched GT Apeiron Therapeutics...
...Peanut (DBV-712) BiomX Inc. DBV Technologies S.A. Genmab A/S GT Healthcare Capital Partners Janssen JSR Corp. Merck & Co. Inc. Aimmune Therapeutics Inc. Exscientia Ltd. CD38 GT Apeiron Therapeutics...
Items per page:
1 - 1 of 1
BioCentury | Jun 11, 2019
Company News

June 11 Company Quick Takes: Genmab, Janssen together again on CD38; plus GT Apeiron’s launch; BiomX, Aimmune, Keytruda

...AI play GT Apeiron launches with $27M, Exscientia deal GT Healthcare Capital Partners launched GT Apeiron Therapeutics...
...Peanut (DBV-712) BiomX Inc. DBV Technologies S.A. Genmab A/S GT Healthcare Capital Partners Janssen JSR Corp. Merck & Co. Inc. Aimmune Therapeutics Inc. Exscientia Ltd. CD38 GT Apeiron Therapeutics...
Items per page:
1 - 1 of 1